BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ziprasidone readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Ziprasidone\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03781115-8549@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20270210
DTEND;VALUE=DATE:20270211
SUMMARY:Ziprasidone: Phase 1 readout est. (NCT03781115)
DESCRIPTION:Ziprasidone\, phase 1\, Schizophrenia.\nStudy: Proposal To Deve
 lop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia\nEstimate
 d primary completion: 10 February 2027. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/ziprasidone#upcoming-events\nRegistry record: https://c
 linicaltrials.gov/study/NCT03781115
URL:https://assetmemo.bio/drug/ziprasidone#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
